Skip to main content
. 2019 Mar-Apr;10(2):106–114. doi: 10.4103/idoj.IDOJ_260_18

Table 1.

Comparative efficacies of immunological and molecular markers in diagnosis of leprosy

Name of the test Types of leprosy
Sensitivity/Specificity (%)
PB patients MB patients
Percent (%) positivity
Serological marker (PGL-1) 0-40%[10,11,12,27] 70-95%[10,11,12,27] 91%[27]
Evaluation of dipstick assay using ND-O-BSA-based ELISA - - 94.9% concordance with ELISA[24]
ML-flow test 40%[27,28] 97.4%[27,28] 97.4%/90.2%[27,28]
35-kD-based serology 46.7%[39] 98.5%[39] 98.4%/100%[40]
90%/97.5%[42]
NDO-LID rapid test 15.4-21.2%[58] 83.3-87%[58] 87%/96.1%[58]
PCR using gene targetRLEP 73%[67]
83%[70]
100%[67,68]
96.6%[71]
73.6%/100%[67]
87.1%[72]
PCR using 16SrRNA gene target 50%[71] 100%[71] 51%/100%[70]
PCR using Ag85B gene target 80%9[72] 100%[72] 56%/100%[70]
PCR using 18kDa gene target 74%[73] 99%[73] 100%/83%[73]
Proline-rich antigen (pra-36 kDa) 36-60%[75,76,77] 87-100%[75,76,77] -
Multiplex PCR 83%[68] 100%[68] -

#Reference numbers have been super fixed against the values